Daniel Trencher Sells 1,000 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Daniel Trencher sold 1,000 shares of Teladoc Health stock in a transaction that occurred on Wednesday, April 17th. The stock was sold at an average price of $13.21, for a total transaction of $13,210.00. Following the transaction, the insider now directly owns 26,192 shares in the company, valued at $345,996.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Daniel Trencher also recently made the following trade(s):

• On Monday, March 18th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The shares were sold at an average price of $15.18, for a total transaction of $15,180.00.
• On Monday, March 4th, Daniel Trencher sold 6,780 shares of Teladoc Health stock. The stock was sold at an average price of $14.52, for a total transaction of $98,445.60.
• On Tuesday, February 20th, Daniel Trencher sold 1,000 shares of Teladoc Health stock. The shares were sold at an average price of $20.64, for a total value of $20,640.00.

Teladoc Health Trading Up 0.3 %

Shares of TDOC opened at $13.18 on Friday. Teladoc Health, Inc. has a 1-year low of $12.93 and a 1-year high of $30.41. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. The firm’s 50-day moving average price is $15.74 and its 200-day moving average price is $17.95. The firm has a market capitalization of $2.23 billion, a price-to-earnings ratio of -9.84 and a beta of 0.94.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.05. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The business had revenue of $660.50 million for the quarter, compared to analysts’ expectations of $670.79 million. During the same period in the previous year, the firm posted ($0.23) EPS. The business’s revenue was up 3.6% on a year-over-year basis. Sell-side analysts anticipate that Teladoc Health, Inc. will post -1.07 EPS for the current year.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds have recently made changes to their positions in TDOC. Granite Bay Wealth Management LLC bought a new position in Teladoc Health in the third quarter worth $3,675,000. Sowell Financial Services LLC grew its position in shares of Teladoc Health by 40.8% in the 4th quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock worth $407,000 after buying an additional 5,475 shares during the period. Lecap Asset Management Ltd. bought a new position in shares of Teladoc Health in the 4th quarter worth about $1,530,000. Deutsche Bank AG lifted its position in Teladoc Health by 12.4% during the 3rd quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock valued at $5,598,000 after acquiring an additional 33,287 shares during the period. Finally, Sherbrooke Park Advisers LLC bought a new stake in Teladoc Health during the third quarter worth about $680,000. 76.82% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on TDOC shares. SVB Leerink started coverage on Teladoc Health in a report on Monday, February 26th. They set a “market perform” rating and a $17.00 target price for the company. Royal Bank of Canada dropped their price objective on Teladoc Health from $30.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, February 21st. DA Davidson cut their target price on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Friday, April 5th. Finally, Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a report on Thursday, February 29th. They issued an “overweight” rating and a $22.00 price target on the stock. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $22.23.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.